• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性帕金森病伴白质病变患者脑脊液 Aβ42 减少。

Decreased Cerebrospinal Fluid Aβ42 in Patients with Idiopathic Parkinson's Disease and White Matter Lesions.

机构信息

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Center for Neurology, Academic Specialist Center, Stockholm, Sweden.

出版信息

J Parkinsons Dis. 2019;9(2):361-367. doi: 10.3233/JPD-181486.

DOI:10.3233/JPD-181486
PMID:30714972
Abstract

BACKGROUND

Cerebral small vessel disease (SVD), often manifesting as white matter lesions (WMLs), and Parkinson's disease (PD) are common disorders whose prevalence increases with age. Vascular risk factors contribute to SVD, but their role in PD is less clear.

OBJECTIVES

The study objective was to investigate the frequency and grade of WMLs in PD, and their association with clinical and biochemical parameters.

METHODS

In total, 100 consecutive patients with available magnetic resonance imaging were included. Vascular risk factors including smoking, hypertension, diabetes type 2, atrial fibrillation, heart insufficiency and hypercholesterolemia were assessed. In 50 patients that had underwent lumbar puncture, cerebrospinal fluid (csf) levels of beta-amyloid1-42, tau and phospho-tau were measured.

RESULTS

WMLs were present in 86 of 100 patients. Increasing WML severity was independently associated with increased age and lower csf beta-amyloid1-42.

CONCLUSIONS

In our study, WMLs were very common in patients with PD, and were associated with low levels of csf beta-amyloid1-42. Longitudinal studies would increase understanding of the interplay between WMLs and amyloid pathology in PD.

摘要

背景

脑小血管病(SVD)常表现为脑白质病变(WMLs),帕金森病(PD)是常见疾病,其患病率随年龄增长而增加。血管危险因素与 SVD 有关,但在 PD 中的作用尚不清楚。

目的

本研究旨在探讨 PD 患者 WMLs 的频率和严重程度及其与临床和生化参数的关系。

方法

共纳入 100 例有磁共振成像(MRI)结果的连续患者。评估了吸烟、高血压、2 型糖尿病、心房颤动、心力衰竭和高胆固醇血症等血管危险因素。在 50 例行腰椎穿刺的患者中,测量了脑脊液(CSF)中β-淀粉样蛋白 1-42、tau 和磷酸化 tau 的水平。

结果

100 例患者中有 86 例存在 WMLs。WML 严重程度的增加与年龄的增加和 CSF 中β-淀粉样蛋白 1-42 的降低独立相关。

结论

在本研究中,PD 患者的 WMLs 非常常见,与 CSF 中β-淀粉样蛋白 1-42 水平降低有关。纵向研究将增加对 WMLs 和 PD 中淀粉样蛋白病理学之间相互作用的理解。

相似文献

1
Decreased Cerebrospinal Fluid Aβ42 in Patients with Idiopathic Parkinson's Disease and White Matter Lesions.特发性帕金森病伴白质病变患者脑脊液 Aβ42 减少。
J Parkinsons Dis. 2019;9(2):361-367. doi: 10.3233/JPD-181486.
2
Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.血浆 Aβ(淀粉样蛋白-β)水平与小血管疾病的严重程度和进展。
Stroke. 2018 Apr;49(4):884-890. doi: 10.1161/STROKEAHA.117.019810. Epub 2018 Mar 14.
3
Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.认知正常老年人脑脊液 Aβ42 和 Aβ40 水平降低与脑白质病变有关。
J Alzheimers Dis. 2018;62(4):1877-1886. doi: 10.3233/JAD-170950.
4
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.帕金森病中的白质高信号、脑脊液淀粉样β蛋白与痴呆
J Neurol Sci. 2016 Aug 15;367:284-90. doi: 10.1016/j.jns.2016.06.009. Epub 2016 Jun 11.
5
Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.用于帕金森综合征伴痴呆鉴别诊断的Tau蛋白、β-淀粉样蛋白₁₋₄₂和簇集蛋白脑脊液水平
J Neurol Sci. 2014 Aug 15;343(1-2):120-4. doi: 10.1016/j.jns.2014.05.052. Epub 2014 Jun 2.
6
Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.富含亮氨酸重复激酶2(LRRK2)突变携带者的脑脊液生物标志物与临床特征
Mov Disord. 2016 Jun;31(6):906-14. doi: 10.1002/mds.26591. Epub 2016 Apr 4.
7
Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.帕金森病患者脑脊液生物标志物与结构脑网络特性之间的关系。
Mov Disord. 2018 Mar;33(3):431-439. doi: 10.1002/mds.27284. Epub 2018 Feb 13.
8
Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.淀粉样蛋白β和α-突触核蛋白脑脊液生物标志物与早期帕金森病的认知
Parkinsonism Relat Disord. 2015 Jul;21(7):758-64. doi: 10.1016/j.parkreldis.2015.04.027. Epub 2015 May 2.
9
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.认知功能正常的帕金森病患者自然人群中的脑脊液阿尔茨海默病生物标志物与血脑屏障完整性。
CNS Neurol Disord Drug Targets. 2017;16(3):339-345. doi: 10.2174/1871527316666161205123123.
10
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.在早期未经治疗的帕金森病中,CSF 淀粉样蛋白-β 和 tau 蛋白与认知表现的关系:挪威 ParkWest 研究。
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1080-6. doi: 10.1136/jnnp.2009.199950. Epub 2010 Jun 14.

引用本文的文献

1
Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development.社论:神经退行性疾病研究中的体液生物标志物:对病理生理学的新见解,以支持临床实践和药物开发。
Front Neurol. 2023 Jan 17;14:1103116. doi: 10.3389/fneur.2023.1103116. eCollection 2023.